• HTG is Accelerating Precision Medicine

    From diagnosis to treatment, HTG is harnessing the power of transcriptome-wide profiling to drive translational research, clinical diagnostics and targeted therapeutics across a variety of disease areas.

    Learn More

  • HTG Transcriptome Panel Available Now

    Simplify gene expression analysis with our new comprehensive human transcriptome panel.

    Learn More

  • HTG Therapeutics

    Unlocking a differentiated  and disruptive approach to transformative drug discovery by leveraging proprietary RNA platform technologies to develop candidates with superior efficacy and safety profiles.

    LEARN MORE

 

HTG is a life science company advancing precision medicine by leveraging its innovative transcriptome-wide profiling technology to develop profiling diagnostics and novel drug candidates to determine the right therapy for the right patient.

News & Events

2022 ASCO Annual Meeting

June 3-7 | Join us at booth 3135 in Chicago at the 2022 ASCO Annual Meeting and Expo.

Posted on:

Keep Reading

ESMO CONGRESS 2022

SEPTEMBER 9-13, 2022 | Join us at the European Society for Medical Oncology Congress in Paris, France

Posted on:

Keep Reading

The Festival of Genomics & Biodata 2023

January 25-26 | Come and see us in London at the 2023 Festival of Genomics

Posted on:

Keep Reading

HTG Molecular Diagnostics to Participate in the H.C. Wainwright Global Investment Conference

TUCSON, Ariz. , May 17, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that management will participate virtually in the H.C….

Keep Reading

HTG Molecular Diagnostics Reports First Quarter 2022 Results

Call scheduled for today, May 12, at 4:30 pm ET TUCSON, Ariz. , May 12, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today reported recent business…

Keep Reading

HTG Molecular Diagnostics to Announce Q1 2022 Financial Results and Host Conference Call on Thursday, May 12

TUCSON, Ariz. , May 05, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that it will report its financial results for the quarter ended…

Keep Reading

Publications

Read white papers or journal publications and view other scientific content. 

White Papers

Therapeutics

Posters

Abstracts

Peer Reviewed Publications

Editorials

Reviews


Careers at HTG

At HTG, we are always looking for talented individuals to help us deliver our next-generation sequencing-based products throughout the world.

New Careers

See All Careers


Page last updated May 05, 2022